Canaccord lowered the firm’s price target on Enovis (ENOV) to $70 from $75 and keeps a Buy rating on the shares. The firm updated its model following Q1 results and the release of its 10Q.Canaccord lowered the price target by applying the same EV/Sales multiple in their last valuation update. While the comp group valuation average is slightly higher and their 2026 revenue estimate has risen, they impose a larger discount to the comp group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
